Latest News
Feature
Time Warp: Fax Machines Still Common in Oncology Practice. Why?
Oncologists are among the many specialists across the country at the mercy of telecopiers.
Conference Coverage
Debate Over Axial Involvement in Psoriatic Arthritis Still Unresolved Despite New Studies
Data from two studies corroborated what was already known about axial psoriatic arthritis rather than help define or differentiate it further from...
Latest News
Trading TV Time for Physical Activity Boosts Healthy Aging
For each increase of 2 hours per day spent sitting and watching television, the odds of healthy aging dropped by 12%.
News from the FDA/CDC
Pyzchiva Receives FDA Approval as Third Ustekinumab Biosimilar
The biosimilar is approved for all indications of the reference medication, Stelara, and will launch in February 2025.
Latest News
Exercise Plus GLP-1 RAs Upped Weight Loss, Bone Retention
Study finds combination of GLP-1 RAs and exercise increased weight loss and maintained bone health.
From the Journals
Form of B12 Deficiency Affecting the Central Nervous System May Be New Autoimmune Disease
The findings uncover “yet another example of a disease where antibodies getting into the brain are the problem.”
Conference Coverage
Psoriatic Arthritis Symptoms Relieved with TYK2 Inhibitor in Phase 2 Trial
More than half of patients assigned to TAK-279 achieved ACR20 at 12 weeks, compared with 30% of patients assigned to placebo in a phase 2 clinical...
Conference Coverage
Psoriatic Arthritis Drug Candidate Sonelokimab Yields Significant Improvements in Phase 2 Trial
Patients receiving sonelokimab experienced higher treatment response in ACR20, ACR50, and PASI90 than those in the placebo group.
Latest News
FDA Proposes that Interchangeability Status for Biosimilars Doesn’t Need Switching Studies
The new draft guidance reflects updated scientific thinking on biosimilars, the agency said.
From the Journals
Baricitinib Outperforms TNF Inhibitors in Real-World RA Trial
In a real-world trial, baricitinib was favored over TNF inhibitors in clinical and patient-reported outcomes after 12 weeks, but one expert...
Conference Coverage
Patient-Driven Care Plus Telemonitoring Yields Promising Results for Spondyloarthritis
Patient-initiated care with or without remote monitoring for spondyloarthritis has been shown to work just as well as usual face-to-face care in...